Prognostic role of simple inflammatory biomarkers in patients with severe COVID-19: an observational study.

IF 0.3 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Hippokratia Pub Date : 2022-04-01
M P Ntalouka, I Pantazopoulos, A G Brotis, A Pagonis, I Vatsiou, A Chatzis, C N Rarras, P Kotsi, K I Gourgoulianis, E M Arnaoutoglou
{"title":"Prognostic role of simple inflammatory biomarkers in patients with severe COVID-19: an observational study.","authors":"M P Ntalouka, I Pantazopoulos, A G Brotis, A Pagonis, I Vatsiou, A Chatzis, C N Rarras, P Kotsi, K I Gourgoulianis, E M Arnaoutoglou","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Simple inflammatory biomarkers, such as neutrophil to lymphocyte ratio (NLR), could serve as prognosis indicators in patients with Coronavirus disease 2019 (COVID-19). The utility of on-admission inflammatory biomarkers in predicting outcomes was investigated in patients suffering from severe COVID-19 infection.</p><p><strong>Methods: </strong>We performed a retrospective study to assess the role of white blood count (WBC), neutrophils (N), lymphocyte (L), platelets (PLTs), C-reactive protein (CRP), reverse transcription polymerase chain reaction (RT-PCR), NLR (N/L), PLR (P/L), dv (derived variation of)-NLR (N/WBC-L), LNR (L/N), dv (derived variation of)-LNR (L/WBC-N), and CLR (CRP/L), in predicting the need for high-flow nasal cannula (HFNC) use, admission to Intensive Care Unit (ICU), and death in adult patients with severe COVID-19 admitted to the Department of Respiratory Medicine from April to September 2021.</p><p><strong>Results: </strong>One hundred and fifteen patients (60 % males) with a mean age of 57.7 ± 16.3 years were included. Thirty-seven patients (32.2 %) required escalation with HFNC, eight patients (7 %) were admitted to the ICU, and nine patients (7.8%) died. Based on univariate analysis, CRP [odds ratio (OR): 1.25, 95 % confidence interval (CI): 1.1-1.42), LNR (OR: 0.015, 95 % CI: 0.00-0.35), dv-NLR (OR: 5*10<sup>6</sup>, 95 % CI: 26.7-9*10<sup>9</sup>), CLR (OR: 7*10<sup>58</sup>, 95 % CI: 3*10<sup>25</sup>-2*10<sup>92</sup>), length of hospitalization (LOH; OR: 1.44, 95 % CI: 1.22-1.63), dyspnea at presentation (OR: 2.83, 95 % CI: 1.23-6.52), and ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO<sub>2</sub>/FiO<sub>2</sub>) on admission (OR: 0.967, 95 % CI: 0.952-0.983) were independent predictors for oxygen requirements. However, the multivariate analysis showed that LNR (OR: 1.686e0<sup>-4</sup>, 95 % CI: 6.441e00<sup>-8</sup>-0.441), PaO<sub>2</sub>/FiO<sub>2</sub> on admission (OR: 0.965, 95 % CI: 0.941-0.989), and LOH (OR: 1.717, 95 % CI: 1.274-2.314) were the most important predictor for HFNC use. Nasal congestion at presentation (OR: 11.5, 95 % CI: 1.61-82.8) was a unique and independent predictor for ICU admission. As far as death is concerned, the univariate analysis identified elevated CRP (OR: 1.11, 95 % CI: 1.0-1.24), low RT-PCR (OR: 0.829, 95 % CI: 0.688-0.999), high CLR (OR: 3.2*10<sup>33</sup>, 95 % CI: 5.8-1.8*10<sup>66</sup>), age (OR: 1.08, 95 % CI: 1.02-1.14), body mass index (BMI) over 30 (OR: 5.25, 95 % CI: 1.26-21.96), the chronic use of angiotensin-converting enzyme inhibitors (OR: 5.72, 95 % CI: 1.35-24.09), nitrates (OR: 14.85, 95 % CI: 1.81-121.8), diuretics (OR: 8.21, 95 % CI: 1.97-34.32), PaO<sub>2</sub>/FiO<sub>2</sub> on admission (OR: 0.983, 95 % CI: 0.970-0.998), and nasal congestion at presentation (OR: 9.81, 95 % CI: 1.40-68.68) as independent predictors. However, the multivariate analysis pinpointed that obesity (BMI >30) (OR: 10.498, 95 % CI: 1.107-99.572) remained the most important predictor for death.</p><p><strong>Conclusion: </strong>LNR and PaO<sub>2</sub>/FiO<sub>2</sub> on admission could be used to timely identify patients requiring HFNC during hospitalization, while obesity (BMI >30) could be an independent predictor of death. Nasal congestion emerges as a unique predictor for ICU admission. HIPPOKRATIA 2022, 26 (2):70-77.</p>","PeriodicalId":50405,"journal":{"name":"Hippokratia","volume":"26 2","pages":"70-77"},"PeriodicalIF":0.3000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177850/pdf/hippokratia-26-70.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hippokratia","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background/aim: Simple inflammatory biomarkers, such as neutrophil to lymphocyte ratio (NLR), could serve as prognosis indicators in patients with Coronavirus disease 2019 (COVID-19). The utility of on-admission inflammatory biomarkers in predicting outcomes was investigated in patients suffering from severe COVID-19 infection.

Methods: We performed a retrospective study to assess the role of white blood count (WBC), neutrophils (N), lymphocyte (L), platelets (PLTs), C-reactive protein (CRP), reverse transcription polymerase chain reaction (RT-PCR), NLR (N/L), PLR (P/L), dv (derived variation of)-NLR (N/WBC-L), LNR (L/N), dv (derived variation of)-LNR (L/WBC-N), and CLR (CRP/L), in predicting the need for high-flow nasal cannula (HFNC) use, admission to Intensive Care Unit (ICU), and death in adult patients with severe COVID-19 admitted to the Department of Respiratory Medicine from April to September 2021.

Results: One hundred and fifteen patients (60 % males) with a mean age of 57.7 ± 16.3 years were included. Thirty-seven patients (32.2 %) required escalation with HFNC, eight patients (7 %) were admitted to the ICU, and nine patients (7.8%) died. Based on univariate analysis, CRP [odds ratio (OR): 1.25, 95 % confidence interval (CI): 1.1-1.42), LNR (OR: 0.015, 95 % CI: 0.00-0.35), dv-NLR (OR: 5*106, 95 % CI: 26.7-9*109), CLR (OR: 7*1058, 95 % CI: 3*1025-2*1092), length of hospitalization (LOH; OR: 1.44, 95 % CI: 1.22-1.63), dyspnea at presentation (OR: 2.83, 95 % CI: 1.23-6.52), and ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) on admission (OR: 0.967, 95 % CI: 0.952-0.983) were independent predictors for oxygen requirements. However, the multivariate analysis showed that LNR (OR: 1.686e0-4, 95 % CI: 6.441e00-8-0.441), PaO2/FiO2 on admission (OR: 0.965, 95 % CI: 0.941-0.989), and LOH (OR: 1.717, 95 % CI: 1.274-2.314) were the most important predictor for HFNC use. Nasal congestion at presentation (OR: 11.5, 95 % CI: 1.61-82.8) was a unique and independent predictor for ICU admission. As far as death is concerned, the univariate analysis identified elevated CRP (OR: 1.11, 95 % CI: 1.0-1.24), low RT-PCR (OR: 0.829, 95 % CI: 0.688-0.999), high CLR (OR: 3.2*1033, 95 % CI: 5.8-1.8*1066), age (OR: 1.08, 95 % CI: 1.02-1.14), body mass index (BMI) over 30 (OR: 5.25, 95 % CI: 1.26-21.96), the chronic use of angiotensin-converting enzyme inhibitors (OR: 5.72, 95 % CI: 1.35-24.09), nitrates (OR: 14.85, 95 % CI: 1.81-121.8), diuretics (OR: 8.21, 95 % CI: 1.97-34.32), PaO2/FiO2 on admission (OR: 0.983, 95 % CI: 0.970-0.998), and nasal congestion at presentation (OR: 9.81, 95 % CI: 1.40-68.68) as independent predictors. However, the multivariate analysis pinpointed that obesity (BMI >30) (OR: 10.498, 95 % CI: 1.107-99.572) remained the most important predictor for death.

Conclusion: LNR and PaO2/FiO2 on admission could be used to timely identify patients requiring HFNC during hospitalization, while obesity (BMI >30) could be an independent predictor of death. Nasal congestion emerges as a unique predictor for ICU admission. HIPPOKRATIA 2022, 26 (2):70-77.

简单炎症生物标志物在重症新冠肺炎患者预后中的作用:一项观察性研究。
背景/目的:简单的炎症生物标志物,如中性粒细胞与淋巴细胞比率(NLR),可以作为2019冠状病毒病(新冠肺炎)患者的预后指标。研究了严重新冠肺炎感染患者入院时炎症生物标志物在预测结果中的作用。方法:我们进行了一项回顾性研究,以评估白细胞计数(WBC)、中性粒细胞(N)、淋巴细胞(L)、血小板(PLT)、C反应蛋白(CRP)、逆转录聚合酶链式反应(RT-PCR)、NLR(N/L)、PLR(P/L)、dv(衍生变异)-NLR(N/WBC-L)、LNR(L/N)、dv(衍生变异的)-LNR(L/WBC-N)和CLR(CRP/L)的作用,预测2021年4月至9月呼吸内科收治的成年重症新冠肺炎患者对高流量鼻插管(HFNC)使用的需求、重症监护室(ICU)的入院情况和死亡情况。结果:包括115名平均年龄为57.7±16.3岁的患者(60%为男性)。37名患者(32.2%)需要升级HFNC,8名患者(7%)入住ICU,9名患者(7.8%)死亡。基于单变量分析,CRP[比值比(OR):1.25,95%置信区间(CI):1.1-1.42),LNR(OR:0.015,95%CI:0.00-0.35),dv-NLR(OR:5*106,95%CI:26.7-9*109),CLR(OR:7*1058,95%CI:3*1025-2*1092),住院时间(LOH;OR:1.44,95%CI:1.22-1.63),出现呼吸困难(OR:2.83,95%CI:1.23-6.52),动脉氧分压与吸入氧分数的比值(PaO2/FiO2)入院时(OR:0.967,95%CI:0.952-0.983)是氧气需求的独立预测因素。然而,多变量分析显示,LNR(OR:1.686e0-4,95%CI:6.441e0-8-0.441)、入院时的PaO2/FiO2(OR:0.965,95%CI:0.941-0.989)和LOH(OR:1.717,95%CI:1.274-2.314)是HFNC使用的最重要预测因素。出现时的鼻腔充血(OR:11.5,95%CI:1.61-82.8)是ICU入院的一个独特且独立的预测因素。就死亡而言,单因素分析确定CRP升高(OR:1.11,95%CI:1.0-1.24),RT-PCR低(OR:0.829,95%CI:0.688-0.999),CLR高(OR:3.2*1033,95%CI:5.8-1.8*1066),年龄(OR:1.08,95%CI:1.02-1.14),体重指数(BMI)超过30(OR:5.25,95%CI:1.26-21.96),长期使用血管紧张素转换酶抑制剂(OR:5.72,95%CI:1.35-24.09),硝酸盐(OR:14.85,95%CI:1.81-121.8)、利尿剂(OR:8.21,95%CI:1.97-34.32)、入院时的PaO2/FiO2(OR:0.983,95%CI:0.970-0.998)和出现时的鼻塞(OR:9.81,95%CI+1.40-68.68)作为独立预测因素。然而,多变量分析表明,肥胖(BMI>30)(OR:10.498,95%CI:1.107-99.572)仍然是死亡的最重要预测因素。结论:入院时的LNR和PaO2/FiO2可用于及时识别住院期间需要HFNC的患者,而肥胖(BMI>30)可能是死亡的独立预测因素。鼻腔充血是ICU入院的一个独特预测因素。海马2022,26(2):70-77。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hippokratia
Hippokratia MEDICINE, GENERAL & INTERNAL-
CiteScore
1.10
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊介绍: Hippokratia journal is a quarterly issued, open access, peer reviewed, general medical journal, published in Thessaloniki, Greece. It is a forum for all medical specialties. The journal is published continuously since 1997, its official language is English and all submitted manuscripts undergo peer review by two independent reviewers, assigned by the Editor (double blinded review process). Hippokratia journal is managed by its Editorial Board and has an International Advisory Committee and over 500 expert Reviewers covering all medical specialties and additionally Technical Reviewers, Statisticians, Image processing Experts and a journal Secretary. The Society “Friends of Hippokratia Journal” has the financial management of both the printed and electronic edition of the journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信